TEZEPELUMAB EFFICACY ACCORDING TO US OMALIZUMAB ELIGIBILITY: RESULTS FROM THE NAVIGATOR PHASE 3 STUDY

被引：0
|
作者：
Israel, E.
Chupp, G.
Colice, G.
Cook, B.
Ambrose, C.
Roseti, S.
Hellqvist, A.
Llanos-Ackert, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2021年 / 127卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
D011
引用
收藏
页码：S14 / S15
页数：2
相关论文
共 50 条
  • [1] Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study
    Corren, Jonathan
    Ambrose, Christopher S. S.
    Griffiths, Janet M. M.
    Hellqvist, Asa
    Lindsley, Andrew W. W.
    Llanos, Jean-Pierre
    Colice, Gene
    Menzies-Gow, Andrew
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04): : 417 - 428
  • [2] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
    Kraft, M.
    Chupp, G. L.
    Reeh, K.
    Lindsley, A. W.
    Cook, B.
    Hunter, G.
    Ambrose, C. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
    Carr, Tara
    Bernstein, Jonathan
    Cook, Bill
    Hunter, Gillian
    Ambrose, Chris
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB152 - AB152
  • [4] Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Corren, Jonathan
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Griffiths, Janet
    Hellqvist, Asa
    Bowen, Karin
    Kaur, Primal
    Almqvist, Gun
    Ponnarambil, Sandhia
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB249 - AB249
  • [5] Efficacy of tezepelumab in patients with severe, uncontrolled asthma, according to baseline blood eosinophil count and allergic status: results from the phase 3 NAVIGATOR study
    Menzies-Gow, A.
    Corren, J.
    Cook, B.
    Kmita, K.
    Llanos-Ackert, J.
    Colice, G.
    Ambrose, C. S.
    [J]. ALLERGY, 2021, 76 : 21 - 22
  • [6] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY PRIOR OMALIZUMAB USE: A POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY
    Menzies-Gow, A.
    Colice, G.
    Ambrose, C. S.
    Martin, N.
    Llanos, J. P.
    Hellqvist, A.
    Cook, B.
    Caminati, M.
    [J]. THORAX, 2023, 78 (SUPPL_4) : A273 - A274
  • [7] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Prior Omalizumab Use: A Post Hoc Analysis of the Phase 3 Navigator Study
    Menzies-Gow, A.
    Colice, G.
    Ambrose, C. S.
    Llanos, J.
    Hellqvist, A.
    Cook, B.
    Caminati, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [8] EFFICACY OF TEZEPELUMAB ACCORDING TO AGE AT ASTHMA ONSET IN NAVIGATOR
    Brusselle, G.
    Spahn, J. D.
    Hunter, G.
    Martin, N.
    Llanos-Ackert, J-P
    Ponnarambil, S.
    [J]. THORAX, 2022, 77 : A33 - A33
  • [9] Efficacy of tezepelumab according to age at asthma onset in NAVIGATOR
    Brusselle, G.
    Spahn, J.
    Hunter, G.
    Martin, N.
    Llanos-Ackert, J.
    Ponnarambil, S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [10] Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study
    Ishizuka, Tamotsu
    Menzies-Gow, Andrew
    Okada, Hiroshi
    Fukushima, Yasushi
    Hayashi, Nobuya
    Colice, Gene
    Ponnarambil, Sandhia
    Hunter, Gillian
    Odajima, Hiroshi
    Ebisawa, Motohiro
    [J]. ALLERGOLOGY INTERNATIONAL, 2023, 72 (01) : 82 - 88
12345